- view fewer
Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.
J Heart Lung Transplant
Cytomegalovirus (CMV) has been associated with morbidity, including chronic allograft rejection, in transplant recipients. Data from adult centers suggests that CMV hyperimmune globulin (CMVIG) and ganciclovir together are superior in preventing CMV viremia than ganciclovir alone.
|Title:||Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.|
|Keywords:||Adolescent, Antiviral Agents, Bronchiolitis Obliterans, Child, Child, Preschool, Cytomegalovirus Infections, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Ganciclovir, Graft Rejection, Humans, Immunoglobulins, Incidence, Infant, Lung Transplantation, Male, Proportional Hazards Models, Retrospective Studies, Risk Factors, Viremia, Young Adult|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Child Health
Archive Staff Only